AN

Anubhuti Neb

Active Director Director DIN 05180431
DIN 05180431 First appointment Jan 2012 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2012
Shareholding value •••• Premium profile

About Anubhuti Neb

Data last updated:

Anubhuti Neb is a Director at Nebreca Pharma Private Limited (since 2012). The company operates in Healthcare. Nebreca Pharma Private Limited reported revenue of ₹2,938 (FY 2025).

DIN 05180431
Primary Designation Director
Industry Healthcare
First Appointment 24 Jan 2012
Oldest Company Age 22 yrs
Largest company Nebreca Pharma Private Limited · ₹2,938 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nebreca Pharma Private Limited U51397UP2004PTC028410
Director24 Jan 20122004₹2,938 (FY 2025)Active

Board colleagues of Anubhuti Neb

NameDINCompanyDesignation
Rishabh Neb08098821Nebreca Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nebreca Pharma Private Limited
Premium access

Shareholding and investment profile for Anubhuti Neb

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anubhuti Neb

Anubhuti Neb currently holds 1 directorship: Nebreca Pharma Private Limited (Director, since 24 Jan 2012, revenue ₹2,938 (FY 2025)).

Anubhuti Neb was first appointed on 24 Jan 2012 as Director at Nebreca Pharma Private Limited.

The current boards of Anubhuti Neb's companies include Rishabh Neb (Nebreca Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available